Development of a rapid Focus Reduction Neutralization Test Assay for measuring SARS-CoV-2 neutralizing antibodies

SARS-CoV-2 is a recently emerged human coronavirus that escalated to a pandemic. There are currently no approved vaccines for SARS-CoV-2, which causes severe respiratory illness or death. Defining the antibody response to SARS-CoV-2 will be essential for understanding disease progression, long-term...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Curr Protoc Immunol
Egile Nagusiak: Vanderheiden, Abigail, Edara, Venkata Viswanadh, Floyd, Katharine, Kauffman, Robert C., Mantus, Grace, Anderson, Evan, Rouphael, Nadine, Edupuganti, Sri, Shi, Pei-Yong, Menachery, Vineet D., Wrammert, Jens, Suthar, Mehul S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2020
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7864545/
https://ncbi.nlm.nih.gov/pubmed/33215858
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpim.116
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak